CD109 and Marfan syndrome: Additionally, overexpression of MET Proto-Oncogene, Receptor Tyrosine Kinase (MET), CD109 molecule (CD109), and Ezrin (EZR) have been reported as potential biomarkers for the aggressive behavior of MFS [10].